Norges Bank’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $534K | Buy |
+56,939
| New | +$534K | ﹤0.01% | 1621 |
|
|
2025
Q1 | – | Sell |
-30,010
| Closed | -$350K | – | 1106 |
|
|
2024
Q4 | $350K | Buy |
+30,010
| New | +$350K | ﹤0.01% | 1809 |
|
|
2024
Q3 | – | Sell |
-240,415
| Closed | -$5.38M | – | 1152 |
|
|
2024
Q2 | $5.38M | Sell |
240,415
-373,736
| -61% | -$8.36M | ﹤0.01% | 1544 |
|
|
2024
Q1 | $16.9M | Buy |
614,151
+77,979
| +15% | +$2.15M | ﹤0.01% | 1311 |
|
|
2023
Q4 | $16.3M | Sell |
536,172
-215,996
| -29% | -$6.59M | ﹤0.01% | 1329 |
|
|
2023
Q3 | $23.8M | Hold |
752,168
| – | – | ﹤0.01% | 1162 |
|
|
2023
Q2 | $30.7M | Buy |
752,168
+62,846
| +9% | +$2.56M | 0.01% | 1077 |
|
|
2023
Q1 | $25.7M | Sell |
689,322
-167,956
| -20% | -$6.26M | 0.01% | 1161 |
|
|
2022
Q4 | $29.9M | Buy |
857,278
+194,959
| +29% | +$6.8M | 0.01% | 1078 |
|
|
2022
Q3 | $37.1M | Buy |
662,319
+55,946
| +9% | +$3.13M | 0.01% | 892 |
|
|
2022
Q2 | $31.4M | Buy |
606,373
+105,566
| +21% | +$5.46M | 0.01% | 1008 |
|
|
2022
Q1 | $36.4M | Buy |
500,807
+59,047
| +13% | +$4.29M | 0.01% | 1054 |
|
|
2021
Q4 | $52.2M | Sell |
441,760
-170,376
| -28% | -$20.1M | 0.01% | 915 |
|
|
2021
Q3 | $82.1M | Buy |
612,136
+197,417
| +48% | +$26.5M | 0.02% | 696 |
|
|
2021
Q2 | $67.1M | Sell |
414,719
-73,917
| -15% | -$12M | 0.01% | 806 |
|
|
2021
Q1 | $39.2M | Buy |
+488,636
| New | +$39.2M | 0.01% | 1117 |
|
|
2020
Q3 | – | Sell |
-15,000
| Closed | -$315K | – | 2151 |
|
|
2020
Q2 | $315K | Buy |
+15,000
| New | +$315K | ﹤0.01% | 2061 |
|
|
2017
Q1 | – | Sell |
-67,571
| Closed | -$886K | – | 2167 |
|
|
2016
Q4 | $886K | Buy |
+67,571
| New | +$886K | ﹤0.01% | 2068 |
|